Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
HK inno.N (195940 KS)
Watchlist
40
Analysis
Health Care
•
South Korea
HK inno.N Corp. develops and manufactures pharmaceuticals products. The Company develops and sells immune anticancer drugs, blood disease drugs, kidney disease drugs, and other products. HK inno.N conducts businesses across worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
HK inno.N
•
04 Aug 2021 19:09
HK Inno.N Post-Listing Immediate Float Analysis
The real-world float is in the low 20%, which is purely made up of new investors who flowed in through the IPO. This is a fairly neat float...
Sanghyun Park
Follow
220 Views
Share
bullish
•
HK inno.N
•
28 Jul 2021 08:01
HK Inno.N Book Building Results Analysis
The IPO price of HK Inno.N has been determined at 59,000 won (high end of the IPO price range). The demand ratio among the institutional investors...
Douglas Kim
Follow
207 Views
Share
bullish
•
HK inno.N
•
28 Jul 2021 07:24
HK Inno.N Bookbuilding Results: Subscription/Lockup Orders in Detail
HK Inno.N's bookbuilding results are out at DART. This post details the subscription and lockup orders by each investor type.
Sanghyun Park
Follow
237 Views
Share
bullish
•
Krafton
•
20 Jul 2021 20:44
Krafton Listing Date Confirmed as August 10th: Rebalancing Trading Timeline
The listing date of Krafton has been confirmed as August 10th. So, this post examines the index rebalancing trading timeline.
Sanghyun Park
Follow
330 Views
Share
bullish
•
HK inno.N
•
07 Jul 2021 03:30
HK Inno.N (Formerly CJ Healthcare) IPO: Offering Detail & Valuation Issues
This post contains information on HK inno.N's initial public offering and summarizes the local street's general view on the valuation.
Sanghyun Park
Follow
513 Views
Share
First
Previous
4
5
6
7
8
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.2
x